Source: International Congress 2015 – Quality management in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
Haval Balata (Manchester, United Kingdom), Haval Balata, Matthew Evison, Haider Al-Najjar, Phil Barber, Richard Booton, Philip Crosbie. Analysis of PET-CT use across a UK cancer network: Are we adhering to NICE guidelines?. Eur Respir J 2015; 46: Suppl. 59, 4235

Member's Comments

No comment yet.

Related content which might interest you: Diagnosing lung cancer: Choosing the best for your patient Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 National lung cancer tissue diagnosis targets: Are they achievable? Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Reducing the rate of emergency presentation in lung cancer Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Should resection rate increase when PET-CT use increases? An analysis of PET-CT use in large UK lung cancer network 2011 - 2013 Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Number of procedures and time needed to diagnose lung cancer: Being right the first time Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Pneumothoraces in CT guided lung biopsies – Are we too cautious? Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016 Lung cancer in women: What are particularities? Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer Year: 2014 Lung cancer, has it changed in the last ten years? Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Improving survival for NSCLC patients in the national lung cancer audit Source: International Congress 2015 – Quality management in lung cancer Year: 2015 Assessing the local impact of a national lung cancer awareness campaign Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013 The provision of EBUS-TBNA services across a UK lung cancer network; a report from the Greater Manchester and Cheshire Lung Cancer Network EBUS Sub-Group Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 SOS study: Lung cancer detection with chest digital tomosynthesis Source: International Congress 2014 – Risk assessment and tracheal reconstructions Year: 2014 The utility of simulation map by workstation for diagnostic bronchoscopy Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Validating an EBUS service provided by a group of operators with different levels of experience Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016 Variation in lung cancer diagnosis in England Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results? Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions Year: 2016